77th Cellular, Tissue, and Gene Therapies Advisory Committee

77th Cellular, Tissue, and Gene Therapies Advisory Committee

Cellular, Tissue, and Gene Therapies Advisory Committee (CTGTAC) Meeting - Day 1Подробнее

Cellular, Tissue, and Gene Therapies Advisory Committee (CTGTAC) Meeting - Day 1

76th Cellular, Tissue, and Gene Therapies Advisory CommitteeПодробнее

76th Cellular, Tissue, and Gene Therapies Advisory Committee

Cellular, Tissue, and Gene Therapies Advisory Committee (CTGTAC) Meeting - Day 2Подробнее

Cellular, Tissue, and Gene Therapies Advisory Committee (CTGTAC) Meeting - Day 2

73nd Cellular, Tissue and Gene Therapies Advisory Committee - Day 1Подробнее

73nd Cellular, Tissue and Gene Therapies Advisory Committee - Day 1

72nd Cellular, Tissue and Gene Therapies Advisory Committee - Day 1Подробнее

72nd Cellular, Tissue and Gene Therapies Advisory Committee - Day 1

73nd Cellular, Tissue and Gene Therapies Advisory Committee - Day 2Подробнее

73nd Cellular, Tissue and Gene Therapies Advisory Committee - Day 2

71st Meeting of the Cellular, Tissue and Gene Therapies Advisory Committee (CTGTAC)Подробнее

71st Meeting of the Cellular, Tissue and Gene Therapies Advisory Committee (CTGTAC)

Cellular, Tissue and Gene Therapies Advisory Committee (CTGT) MeetingПодробнее

Cellular, Tissue and Gene Therapies Advisory Committee (CTGT) Meeting

72nd Cellular, Tissue and Gene Therapies Advisory Committee - Day 2Подробнее

72nd Cellular, Tissue and Gene Therapies Advisory Committee - Day 2

Sick Cells Community Webinar: Information on the 2023 FDA Advisory Committee for Gene Therapy.Подробнее

Sick Cells Community Webinar: Information on the 2023 FDA Advisory Committee for Gene Therapy.

Equity of Voices series: Tony’s storyПодробнее

Equity of Voices series: Tony’s story

MHBE Standing Advisory Committee Meeting - September 14, 2023Подробнее

MHBE Standing Advisory Committee Meeting - September 14, 2023

3/21 MRT Public Discussion Meeting: Presentations (FDA Perspective and Committee Overview)Подробнее

3/21 MRT Public Discussion Meeting: Presentations (FDA Perspective and Committee Overview)

Advisory Committee Meetings 101: A Conversation with Tim Franson, MDПодробнее

Advisory Committee Meetings 101: A Conversation with Tim Franson, MD

Overview of Standards Setting for Cell/Gene Therapies-- Case StudiesПодробнее

Overview of Standards Setting for Cell/Gene Therapies-- Case Studies

An Update on the Office of Cellular, Tissue and Gene Therapies: Celia Witten, FDAПодробнее

An Update on the Office of Cellular, Tissue and Gene Therapies: Celia Witten, FDA

Cell & Gene Therapy Products 2022 Keynote: Peter Marks, CBER, FDAПодробнее

Cell & Gene Therapy Products 2022 Keynote: Peter Marks, CBER, FDA

FDA’s Clinical Regulatory Perspective: Designing First-In-Human Trial for Cellular and Gene TherapyПодробнее

FDA’s Clinical Regulatory Perspective: Designing First-In-Human Trial for Cellular and Gene Therapy

2021 Gene Therapy Update part 2Подробнее

2021 Gene Therapy Update part 2

Новости